GOLGA8F

Across TCGA pan-cancer cohorts, GOLGA8F RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated GOLGA8F data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher GOLGA8F RNA is associated with better overall survival. In most high-consensus cancer types, elevated GOLGA8F expression acts as an unfavorable survival marker, although some lineages such as BLCA and HNSC show a favorable association.

BLCA, ACC, and HNSC are the cancer types where GOLGA8F RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	II,III,IV	0.751	0.575	.004	84	view →
ACC	OS	Tertile	II,III,IV	0.186	0.732	<.001	54	view →
HNSC	OS	Quartile	IV	0.893	0.239	.009	37	view →
DLBC	OS	Tertile	III,IV	0.172	1.000	.014	33	view →
UVM	OS	Tertile	All	0.248	0.769	.007	27	view →
CHOL	DFS	Quartile	All	0.051	0.476	<.001	21	view →
KICH	DFS	Tertile	III,IV	0.025	0.773	<.001	21	view →
SKCM	DFS	Tertile	IV	0.943	0.159	.031	9	view →
MESO	OS	Tertile	III,IV	0.294	0.440	.045	9	view →
PCPG	OS	Tertile	All	0.904	1.000	.005	9	view →
ESCA	OS	Tertile	All	0.589	0.760	.011	8	view →
LUSC	DFS	Tertile	All	0.725	0.410	.016	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

GOLGA8F–BLCA (OS)

Open the BLCA breakdown →